Something different is coming to ASRM 2026
CooperSurgical is heading to Baltimore this October, and this year, we’re bringing something new. Register your interest below to be the first to hear what we have planned.
ASRM 2026 Scientific Congress and Expo
October 24–28, 2026 | Baltimore Convention Center, Baltimore, MD
An Experience Built
Around Innovation
At ASRM 2026, we’re building an interactive, immersive experience rooted in our Ecosystem of Innovation: a connected suite of solutions designed to support every stage of the fertility journey.
We can’t reveal everything just yet. But we can tell you it’s going to be hands-on, forward-looking, and built around the people who show up every day to push reproductive medicine forward.
More details are coming. Make sure you’re first to hear them.
Will You Be Attending
ASRM 2026?
Let us know by completing the short form below. Once you register, you’ll receive updates directly to your inbox, including:
- The full booth schedule of live demonstrations and expert talks
- Details on hands-on opportunities and on-demand custom sessions
- Early access to product announcements and news from our team
- The chance to connect with our sales team ahead of the event
Register Now
Don’t miss what’s coming. Register your interest today and we’ll keep you updated as the full ASRM 2026 experience takes shape.
I’m Attending ASRM 2026—Keep Me Updated
Explore Our Latest Innovations
Our booth will showcase key products and services from across our Ecosystem of Innovation, including:
The NEW Wallace™ Aspiration Pump
is easy to operate and navigate with minimal setup required.1It is designed to maintain consistent negative pressure during oocyte aspiration to help preserve oocyte integrity.2,3
ViaBL® Super-Fast Blastocyst Vitrification Kit
is designed to vitrify blastocysts in less than 2.5 minutes. Backed by one of largest data sets our complete ViaBL vitrification and warming solution can save up to 26 minutes.4,5
RI Witness® Electronic Witnessing System
is now faster than ever and continually evolving to meet your changing needs.
Select Syndrome Screen℠ test
Harness the power of a comprehensive test with PGT-A and Select Syndrome Screen to receive insights on aneuploidy, mosaicism and select de novo errors. Delivers additional clinical insight and more informed embryo prioritization.
And there’s more we haven’t announced yet.
Scientific Programme
Oral Abstracts
| Abstract | Authors | Programme |
|---|---|---|
|
Donor Perspectives on Predisposition Genetic Testing in Gamete Donor Programs: Are Donors Ready to Take Part?
Learn More
|
|
|
|
Elevated Occurrence and Associated Loss of Heterozygosity Observed in Preimplantation Embryos Screened for Select Microdeletion and Microduplication Syndromes
Learn More
|
|
|
|
From Request to Connection: Adult DCP Contact Requests in a Gamete Bank Dataset – Request Trends, Donor Responsiveness, and Connection Outcomes
Learn More
|
|
Posters
| Abstract | Authors | Programme |
|---|---|---|
|
Can Biopsy Cell Number Be Inferred From Sequencing Profiles and Optimized Through Real Time Vision Guided Trophectoderm Biopsy to Ensure Consistent PGT-A Data Quality?
Learn More
|
|
|
|
Intended Parents’ Perspectives on How Sperm Donor Regulations Affect Donor Diversity and Reproductive Choice
Learn More
|
|
|
|
Discrepancies Between Donor Application and Genetic Consultation in Routine Donor Screening at a Large US Based Sperm Bank Highlight the Necessity of Professional Risk Assessment
Learn More
|
|
|
|
Sperm Donors’ Perceptions of Burden, Privacy, and Safety Under Proposed US Sperm Donation Laws
Learn More
|
|
|
|
The Impact of Fertility Preservation Insurance Mandates on Utilization Rates Amongst Men Diagnosed With Cancer: A Code-based Analysis of Clinical Records
Learn More
|
|
|
|
Whole Chromosome, Segmental, and Mosaic Aneuploidy Across 250,000 Embryos Supports Potential Mechanisms and Clinical Implications for PGT-A
Learn More
|
|
|
|
Segmental Deletions Identified By PGT-A: Parental Origin and Chromosomal Trends in 23,500 Embryo Biopsies
Learn More
|
|
|
|
Simultaneous Preimplantation Genetic Testing (PGT-M) Test Optimization and Testing of Biopsied Samples is Not Associated With an Increased Risk of Inconclusive Results
Learn More
|
|
|
|
IVF Cycle Trajectory and Re-biopsy Outcomes Reveal Sustained Opportunity for Euploid Embryo Identification
Learn More
|
|
Join us as we continue to grow our ecosystem, for generations to come.
References
- Cohen, J., et al. (1986) Follicular aspiration using a syringe suction system may damage the zona pellucida. Journal of In Vitro Fertilization and Embryo Transfer. 3, pp.224–226.
- CooperSurgical data on file.
- ESHRE Working Group on Ultrasound in ART, D’Angelo, A., et al. (2019) Recommendations for good practice in ultrasound: oocyte pick up. Human Reproduction Open, (4), hoz025.
- Ebinger, E., et al. (2026) Shortened blastocyst vitrification achieves live birth rates comparable to standard protocols: an analysis of 3168 cryotransfers. medRxiv, pp 1-22.
- Ebinger, E., et al. (2025) Efficacy and safety of a one-step warming protocol of vitrified blastocyst stage embryos. F S Rep, 2666-3341.
